ArticleFrontiers in medicine2026
Case Report: Adult-onset Still's disease presenting with massive hemorrhagic pericardial effusion without the characteristic rash.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adult-onset Still's disease (AOSD) is a rare systemic autoinflammatory disorder without universally accepted disease-specific biomarkers, although serum ferritin and glycosylated ferritin may provide supportive diagnostic value. Therefore, diagnosis relies on a combination of clinical manifestations, laboratory abnormalities, and exclusion of alternative diagnoses, commonly using criteria such as Yamaguchi or Fautrel. Although serosal involvement has been reported, presentation with massive hemorrhagic pericardial effusion in the absence of the characteristic rash is extremely rare and may mimic tuberculosis, malignancy, or other rheumatic diseases. We report a 67-year-old Asian man who was referred to our department from a local hospital because of persistent cough, fever, and polyserositis predominantly characterized by massive hemorrhagic pericardial effusion. Laboratory evaluation revealed marked systemic inflammation, elevated ferritin levels, a positive interferon-gamma release assay, elevated adenosine deaminase in pericardial fluid, increased tumor markers, and anti-SAE1 positivity, initially raising suspicion for tuberculous pericarditis, malignancy, or autoimmune myopathy. However, comprehensive microbiological, cytological, imaging, and neuromuscular assessments found no evidence supporting these conditions, and the patient did not develop the typical evanescent rash of AOSD. After initiation of diagnostic glucocorticoid therapy, rapid defervescence and marked resolution of serous effusions were observed, supporting the diagnosis. This case highlights an atypical presentation of AOSD and emphasizes that AOSD should be considered in patients with unexplained serositis, particularly hemorrhagic pericardial effusion accompanied by systemic inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.